These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 27639648)

  • 1. Cellular prion protein as a receptor for amyloid-β oligomers in Alzheimer's disease.
    Salazar SV; Strittmatter SM
    Biochem Biophys Res Commun; 2017 Feb; 483(4):1143-1147. PubMed ID: 27639648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein.
    Um JW; Kaufman AC; Kostylev M; Heiss JK; Stagi M; Takahashi H; Kerrisk ME; Vortmeyer A; Wisniewski T; Koleske AJ; Gunther EC; Nygaard HB; Strittmatter SM
    Neuron; 2013 Sep; 79(5):887-902. PubMed ID: 24012003
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic molecules and endogenous ligands regulate the interaction between brain cellular prion protein (PrPC) and metabotropic glutamate receptor 5 (mGluR5).
    Haas LT; Kostylev MA; Strittmatter SM
    J Biol Chem; 2014 Oct; 289(41):28460-77. PubMed ID: 25148681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prion protein ligand, stress-inducible phosphoprotein 1, regulates amyloid-β oligomer toxicity.
    Ostapchenko VG; Beraldo FH; Mohammad AH; Xie YF; Hirata PH; Magalhaes AC; Lamour G; Li H; Maciejewski A; Belrose JC; Teixeira BL; Fahnestock M; Ferreira ST; Cashman NR; Hajj GN; Jackson MF; Choy WY; MacDonald JF; Martins VR; Prado VF; Prado MA
    J Neurosci; 2013 Oct; 33(42):16552-64. PubMed ID: 24133259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligomers of Amyloid β Prevent Physiological Activation of the Cellular Prion Protein-Metabotropic Glutamate Receptor 5 Complex by Glutamate in Alzheimer Disease.
    Haas LT; Strittmatter SM
    J Biol Chem; 2016 Aug; 291(33):17112-21. PubMed ID: 27325698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptotoxic Signaling by Amyloid Beta Oligomers in Alzheimer's Disease Through Prion Protein and mGluR5.
    Brody AH; Strittmatter SM
    Adv Pharmacol; 2018; 82():293-323. PubMed ID: 29413525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide aptamer targeting Aβ-PrP-Fyn axis reduces Alzheimer's disease pathologies in 5XFAD transgenic mouse model.
    Ali T; Klein AN; Vu A; Arifin MI; Hannaoui S; Gilch S
    Cell Mol Life Sci; 2023 May; 80(6):139. PubMed ID: 37149826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of Amyloid β Oligomer Binding to Neurons and Neurotoxicity by the Prion Protein-mGluR5 Complex.
    Beraldo FH; Ostapchenko VG; Caetano FA; Guimaraes AL; Ferretti GD; Daude N; Bertram L; Nogueira KO; Silva JL; Westaway D; Cashman NR; Martins VR; Prado VF; Prado MA
    J Biol Chem; 2016 Oct; 291(42):21945-21955. PubMed ID: 27563063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic and standardized comparison of reported amyloid-β receptors for sufficiency, affinity, and Alzheimer's disease relevance.
    Smith LM; Kostylev MA; Lee S; Strittmatter SM
    J Biol Chem; 2019 Apr; 294(15):6042-6053. PubMed ID: 30787106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons.
    Um JW; Nygaard HB; Heiss JK; Kostylev MA; Stagi M; Vortmeyer A; Wisniewski T; Gunther EC; Strittmatter SM
    Nat Neurosci; 2012 Sep; 15(9):1227-35. PubMed ID: 22820466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Domains of STIP1 responsible for regulating PrPC-dependent amyloid-β oligomer toxicity.
    Maciejewski A; Ostapchenko VG; Beraldo FH; Prado VF; Prado MA; Choy WY
    Biochem J; 2016 Jul; 473(14):2119-30. PubMed ID: 27208175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteolytic shedding of the prion protein via activation of metallopeptidase ADAM10 reduces cellular binding and toxicity of amyloid-β oligomers.
    Jarosz-Griffiths HH; Corbett NJ; Rowland HA; Fisher K; Jones AC; Baron J; Howell GJ; Cowley SA; Chintawar S; Cader MZ; Kellett KAB; Hooper NM
    J Biol Chem; 2019 Apr; 294(17):7085-7097. PubMed ID: 30872401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
    Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
    Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liquid and Hydrogel Phases of PrP
    Kostylev MA; Tuttle MD; Lee S; Klein LE; Takahashi H; Cox TO; Gunther EC; Zilm KW; Strittmatter SM
    Mol Cell; 2018 Nov; 72(3):426-443.e12. PubMed ID: 30401430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes.
    Hamilton A; Zamponi GW; Ferguson SS
    Mol Brain; 2015 Mar; 8():18. PubMed ID: 25888324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
    Aimi T; Suzuki K; Hoshino T; Mizushima T
    J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prions and Neurodegenerative Diseases: A Focus on Alzheimer's Disease.
    Crestini A; Santilli F; Martellucci S; Carbone E; Sorice M; Piscopo P; Mattei V
    J Alzheimers Dis; 2022; 85(2):503-518. PubMed ID: 34864675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accumulation of cellular prion protein within β-amyloid oligomer plaques in aged human brains.
    Takahashi RH; Yokotsuka M; Tobiume M; Sato Y; Hasegawa H; Nagao T; Gouras GK
    Brain Pathol; 2021 Sep; 31(5):e12941. PubMed ID: 33624334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Amyloid-β induced signaling by cellular prion protein and Fyn kinase in Alzheimer disease.
    Um JW; Strittmatter SM
    Prion; 2013; 7(1):37-41. PubMed ID: 22987042
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal cellular prion protein drives fibrillization of amyloid beta and counteracts amyloid beta-mediated neurotoxicity.
    Falker C; Hartmann A; Guett I; Dohler F; Altmeppen H; Betzel C; Schubert R; Thurm D; Wegwitz F; Joshi P; Verderio C; Krasemann S; Glatzel M
    J Neurochem; 2016 Apr; 137(1):88-100. PubMed ID: 26710111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.